Newstral
Article
Ars Technica on 2018-05-04 17:01
Drug made famous by Shkreli’s 5,000% price hike is still $750 a pill
Related news
- Shkreli’s former company is now losing money—even with the 5,000% price hikeArs Technica
- Drug compounder offers $1 alternative to $750 pill whose price was hiked 5,000 %CBC
- Drug with rage-inducing >5,000% price-hike now has $1/pill competitorArs Technica
- BThe aftermath of Martin Shkreli’s drug price hikebrockpress.com
- $750 pill facing a $1 competitorThe Daily Gazette
- MHere’s why Daraprim still costs $750 a pillmarketwatch.com
- Express Scripts backs $1 alternative to $750 pillUSA today
- $750/pill pharma company reverses decision to lower drug priceArs Technica
- DDrug company raises parasite pill price from $13.50 to $750Daily News
- CEO ups drug price from $13.50 to $750 a pillwsfa.com
- $750 a pill? Rival company offers it for $1Philly.com
- FDA approves generic form of $750 pill DaraprimCNN
- Drug to treat parasitic infections Daraprim goes up from $13.50 a pill to $750 a pillamericanbazaaronline.com
- DMartin Shkreli boasted of profits from pill price hikeDaily News
- Take that, Martin Shkreli: Rival companies announce $1 alternative to $750 Daraprim pillWashington Post
- SMartin Shkreli’s Daraprim Scandalseren.bangor.ac.uk
- Pill that cost $13.50 is now $750? Focus turns again to rising drug costscourier-tribune.com
- $750/pill pharma company under investigation by Senate for price gougingArs Technica
- Company behind $750 pill facing antitrust investigation by New York AGreviewjournal.com
- G$750 Pill to Get $1 CompetitionGuardian Liberty Voice